DOCSLIB.ORG

Antibitoic Treatment for Tuberculosis Induces a Profound Dysbiosis of the Gut Microbiome That Persists Long After Therapy Is Completed

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Antibitoic Treatment for Tuberculosis Induces a Profound Dysbiosis of the Gut Microbiome That Persists Long After Therapy Is Completed ANTIBITOIC TREATMENT FOR TUBERCULOSIS INDUCES A PROFOUND DYSBIOSIS OF THE GUT MICROBIOME THAT PERSISTS LONG AFTER THERAPY IS COMPLETED A Thesis Presented to the Faculty of the Weill Cornell Graduate School of Medical Sciences in Partial Fulfillment of the Requirements for the Degree of Masters of Science by Matthew F. Wipperman May 2017 © 2017 Matthew F. Wipperman ABSTRACT Mycobacterium tuberculosis, the cause of Tuberculosis (TB), infects one third of the world’s population and causes substantial mortality worldwide. In its shortest format, treatment of drug sensitive TB requires six months of multidrug therapy with a mixture of broad spectrum and mycobacterial specific antibiotics, and treatment of multidrug resistant TB is much longer. The widespread use of this regimen worldwide makes this one the largest exposures of humans to antimicrobials, yet the effects of antimycobacterial agents on intestinal microbiome composition and long term stability are unknown. We compared the microbiome composition, assessed by both 16S rDNA and metagenomic DNA sequencing, of Haitian TB cases during antimycobacterial treatment and following cure by 6 months of TB therapy. TB treatment does not perturb overall diversity, but nonetheless dramatically depletes multiple immunologically significant commensal bacteria. The perturbation by TB therapy lasts at least 1.5 years after completion of treatment, indicating that the effects of TB treatment are long lasting and perhaps permanent. These results demonstrate that TB treatment has dramatic and durable effects on the intestinal microbiome and highlight unexpected extreme consequences of treatment for the world’s most common infection on human ecology. BIOGRAPHICAL SKETCH NAME POSITION TITLE Wipperman, Matthew Frederick Postdoctoral Researcher at eRA COMMONS USER NAME Memorial Sloan Kettering Cancer Center MFWIPPERMAN DEGREE INSTITUTION AND (if MM/YY FIELD OF STUDY LOCATION applicable) Franklin & Marshall College B.A. 2007 – 2011 Chemistry Lancaster, Pennsylvania Stony Brook University Chemistry and Chemical Ph.D. 2011 – 2015 Stony Brook, New York Biology Stony Brook Medicine Certificate 2013 – 2014 Biomedical science Stony Brook, New York Weill Cornell Medicine Clinical and translational M.Sc. 2015 – 2017 New York, New York research Memorial Sloan Kettering Cancer Center N/A 2015 – present Postdoctoral research New York, New York A. Personal Statement I am interested in using basic science to answer relevant questions in biomedical and translational scientific research. As an undergraduate I had the opportunity to work for four years under Dr. Phyllis Leber, who is a recognized expert in physical organic chemistry. My introduction to laboratory science during this time involved organic synthesis and physical chemistry techniques. I helped provide evidence that multicyclic vinylcyclobutanes rearrange to cyclohexenes via a diradical intermediate. Additionally, I helped characterize the properties of these diradical transition structures, helping to elucidate the mechanics of this class of pericyclic reactions. In graduate school, I worked under Dr. Nicole Sampson, a chemist and chemical biologist, which is where I learned techniques from classical biochemistry. I helped discover and characterize a new class of enzymes that make it possible for M. tuberculosis to metabolize steroids like cholesterol, synthesized chemical inhibitors that could target these enzymes, and helped to elucidate the steps of the cholesterol catabolic pathway. Additionally, I obtained a Certificate in iii Biomedical Science at Stony Brook Medicine, and pursued a translational research project involving the development of pediatric biomarkers for TB disease using cholesterol metabolism as an indicator. Under the guidance of my graduate school co-mentor Dr. Sharon Nachman, I traveled to South Africa and went though the process of obtaining clinical blood samples for my research. This experience helped to form my current interests in using scientific tools to answer questions related to human health. In my current postdoctoral position under Dr. Michael Glickman, a distinguished physician- scientist, I am involved with a large translational research project studying immune and microbiomic predictors of innate resistance to Tuberculosis (TB) infection. I study how the microbiome may affect other aspects of immune function, and how the various stages of TB infection and TB treatment alter microbiomic composition in the short and the long term. Additionally, I am investigating Mycobacterial RecA and how its regulation via phosphorylation affects DNA repair. The interplay between basic science and the clinic interests me greatly. I enjoy working with a multidisciplinary network of individuals to answer medical questions using basic science and technology. I have a history as a highly motivated and self-sufficient researcher who communicates and works well both independently and with others. B. Positions and Honors Experience and Professional Memberships 2010 – Member, American Chemical Society Honors 2012 Best Communicated Research (STEM) Award, Postdoctoral Research Symposium, Stony Brook University 2013 Scholarship, Scholars in the Biomedical Sciences at Stony Brook University C. Contributions to Science 1. Tuberculosis continues to plague humanity as the number one killer of an infectious disease, and although much is known about what risk factors contribute to TB pathogenesis, virtually nothing is known about how the gut microbiome contributes to this risk. I integrated the research fields of TB and the microbiome using clinical samples from cross sectional and cohort studies to demonstrate microbiomic differences between different groups of people. I demonstrated how TB antibiotics affect the microbiome during and post treatment, and have correlated this to immunological health using RNAseq and immunophenotyping. • Matthew F. Wipperman, Dan Fitzgerald, Ying Taur, Sivaranjani Namasivayam, Alan Sher, James M. Bean, Vanni Bucci, Michael S. iv Glickman. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after completion of therapy. Scientific Reviews, 2017, submitted. • Sivaranjani Namasivayam, Mamoudou Maiga, Wuxing Yuan, Vishal Thovarai, Diego L. Costa, Lara R. Mittereder, Matthew F. Wipperman, Michael S. Glickman, Amiran Dzutsev, Giorgio, Trinchieri, Alan Sher. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional antituberculosis therapy. Microbiome. 2017, 5:71. doi: 10.1186/s40168-017-0286-2. 2. The bacterial catabolism of steroids like cholesterol has been described for more than a century, however only recently has this process been implicated in disease pathogenesis, specifically of M. tuberculosis. I discovered and characterized a new class of acyl-CoA dehydrogenase enzymes using biochemical and bioinformatics techniques, and demonstrated their evolutionary distribution. I additionally synthesized an azasteroid inhibitor scaffold of these enzymes. • Matthew F. Wipperman, Meng Yang, Suzanne T. Thomas, and Nicole S. Sampson. Shrinking the FadE proteome of Mycobacterium tuberculosis: Insights into cholesterol metabolism through identification of an a2b2 heterotetrameric acyl coenzyme A dehydrogenase family. Journal of Bacteriology. 2013. J. Bacteriol. 195, 4331–4341. doi: 10.1128/JB.00502-13; PMCID: PMC3807453. • Commentary: Journal of Bacteriology: Voskuil, M. I. Mycobacterium tuberculosis cholesterol catabolism requires a new class of acyl coenzyme A dehydrogenase. 2013. J. Bacteriol. 195, 4319–4321. doi: 10.1128/JB.00867-13; PMCID: PMC3807469 • Highlighted on the cover of the Journal of Bacteriology for the October, 2013 edition. http://jb.asm.org/content/195/19.cover- expansion • Matthew F. Wipperman, Nicole S. Sampson, and Suzanne T. Thomas. Pathogen roid rage: Cholesterol utilization by Mycobacterium tuberculosis. Critical Reviews in Biochemistry anD Molecular Biology. July/August 2014, 49 (4), 269-293. doi:10.3109/10409238.2014.895700; PMCID: PMC4255906 • Meng Yang, Rui Lui, Kip E, Guja, Matthew F. Wipperman, Johnna R. St. Clair, Amber C. Bonds, Miguel Garcia-Diaz, Nicole S. Sampson. Unraveling Cholesterol Catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 a2b2 Acyl-CoA Dehydrogenase Initiates v β-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA. ACS Infectious Disease. 2015. doi: 10.1021/id500033m; PMCID: PMC4489319 3. Understanding the fundamental ways in which carbon-carbon bonds are made and broken has vast implications in our basic understanding of how organic reactions happen. I synthesized bicyclic and tricyclic vinylcyclobutanes, and studied [1,3] sigmatropic rearrangements of these molecules. I demonstrated the fundamental nature of diradical intermediates in this reaction process, and confirmed a theoretical prediction about the electron donating effects of the cyclopropylcarbinyl functionality. • Phyllis A. Leber, George R. Mann, III, William Hancock-Cerutti, Matthew F. Wipperman, Sylvia Zohrabian, Ryan M. Bell, and John E. Baldwin. Thermal Isomerizations of cis,anti,cis- Tricyclo[7.4.0.02,8]triDec-10-ene. The Journal of Organic Chemistry. 2012 77 (7), 3468-3474. doi: 10.1021/jo300082a • Phyllis A. Leber, Anthony J. Nocket, Matthew F. Wipperman, Sylvia Zohrabian, Christopher Y. Bemis, and Munsha K. Sidhu. Experimental Evidence of a Cyclopropylbarbinyl Conjugative Electronic Effect. Organic anD Biomolecular Chemistry. 2013. 11, 5994–5997. doi: 10.1039/C3OB41365A vi TABLE OF CONTENTS Biographical sketch iii List
Load more

Recommended publications
  • Noncontiguous Finished Genome Sequence and Description Of
    TAXONOGENOMICS:GENOME OF A NEW ORGANISM Noncontiguous finished genome sequence and description of Gabonia massiliensis gen. nov., sp. nov. G. Mourembou1,2, J. Rathored1, A. Ndjoyi-Mbiguino4, J. B. Lekana-Douki3,5, F. Fenollar1, C. Robert1, P.-E. Fournier1, D. Raoult1,6 and J. C. Lagier1 1) Aix Marseille Université, URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France, 2) Ecole Doctorale Régionale d’Afrique Centrale, 3) Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, 4) Département de Microbiologie, Laboratoire National de référence IST/sida, Faculté de Médecine, 5) Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Sciences de la Santé B.P., Libreville, Gabon and 6) Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia Abstract Culturomics coupled with taxonogenomics is currently used to isolate and characterize new bacteria. Here we describe the features and complete genome sequence of Gabonia massiliensis strain GM3, an anaerobic Gram negative, non-spore-forming and catalase-positive bacillus isolated from a stool specimen of a healthy Gabonese male youth. Belonging to a new genus called Gabonia, it exhibits a genome of 4 261 752 bp including 37.9% GC content and 3,288 predicted genes. New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. Keywords: Culturomics, Gabonia massiliensis gen. nov. et sp. nov., genome, taxonogenomics, gut microbiota Original Submission: 28 September 2015; Revised Submission: 3 November 2015; Accepted: 4 November 2015 Article published online: 24 November 2015 including 16S rRNA sequence similarity, GC percentage and Corresponding author: J.C.
    [Show full text]
  • Gut Dysbiosis and Neurobehavioral Alterations in Rats Exposed to Silver Nanoparticles Received: 10 January 2017 Angela B
    www.nature.com/scientificreports OPEN Gut Dysbiosis and Neurobehavioral Alterations in Rats Exposed to Silver Nanoparticles Received: 10 January 2017 Angela B. Javurek1, Dhananjay Suresh 2, William G. Spollen3,4, Marcia L. Hart5, Sarah Accepted: 19 April 2017 A. Hansen6, Mark R. Ellersieck7, Nathan J. Bivens 8, Scott A. Givan 3,4,9, Anandhi Published: xx xx xxxx Upendran10,11, Raghuraman Kannan11,12 & Cheryl S. Rosenfeld 4,13,14,15 Due to their antimicrobial properties, silver nanoparticles (AgNPs) are being used in non-edible and edible consumer products. It is not clear though if exposure to these chemicals can exert toxic effects on the host and gut microbiome. Conflicting studies have been reported on whether AgNPs result in gut dysbiosis and other changes within the host. We sought to examine whether exposure of Sprague- Dawley male rats for two weeks to different shapes of AgNPs, cube (AgNC) and sphere (AgNS) affects gut microbiota, select behaviors, and induces histopathological changes in the gastrointestinal system and brain. In the elevated plus maze (EPM), AgNS-exposed rats showed greater number of entries into closed arms and center compared to controls and those exposed to AgNC. AgNS and AgNC treated groups had select reductions in gut microbiota relative to controls. Clostridium spp., Bacteroides uniformis, Christensenellaceae, and Coprococcus eutactus were decreased in AgNC exposed group, whereas, Oscillospira spp., Dehalobacterium spp., Peptococcaeceae, Corynebacterium spp., Aggregatibacter pneumotropica were reduced in AgNS exposed group. Bacterial reductions correlated with select behavioral changes measured in the EPM. No significant histopathological changes were evident in the gastrointestinal system or brain. Findings suggest short-term exposure to AgNS or AgNC can lead to behavioral and gut microbiome changes.
    [Show full text]
  • New Genus, Coprococcus, Twelve New Species, and Emended Descriptions of Four Previously Described Species of Bacteria from Human Feces LILLIAN V
    INTERNATIONAL JOURNAL of SYSTEMATIC BACTERIOLOGY Vol. 24, No. 2 April 1974, p. 260-277 Printed in U.S.A. Copyright 0 1974 International Association of Microbiological Societies New Genus, Coprococcus, Twelve New Species, and Emended Descriptions of Four Previously Described Species of Bacteria from Human Feces LILLIAN V. HOLDEMAN and W. E. C. MOORE Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, Virginia24061 A new genus of anaerobic cocci, Coprococcus, and 12 new species of anaerobes, Coprococcus eutactus, C. catus, C. comes, RuminococCus callidus, R. torques, Streptococcus hansenii, Bacteroides eggerthii, Eubacterium eligens, E. formicigenerans, E. hallii, Lactobacillus rogosae, and Clostridium nexile, are described. Emended descriptions and proposed neotype strains for Strepto- coccus constellatus (Prkvot) comb. nov., S. morbillorum (Prkvot) comb. nov., S. in termedius PrCvot, and Eubacterium biiorme (Eggerth) PrCvot are presented. During quantitative and qualitative studies of The moles percent guanine plus cytosine (G+C) the human fecal flora, a large number of content of the deoxyribonucleic acid (DNA) prepara- previously undescribed bacterial species was tions was determined by the thermal melting point encountered as predominant members of the (T,) method (7) by using an automatic recording flora. Of these species, those for which we have spectrophotometer (Gilford Instrument Laboratories). DNA from Escherichia coli B was included in each set nine or more isolates from six or more persons of analyses as a standard. are described here. In addition, the taxonomic position of some species of cocci is discussed, RESULTS AND DISCUSSION and for Eubacterium biforme (Eggerth) Prbvot, an emended description is presented and a Anaerobic Cocci neotype strain is designated.
    [Show full text]
  • Functional Deficits in Gut Microbiome of Young and Middle-Aged
    nutrients Article Functional Deficits in Gut Microbiome of Young and Middle-Aged Adults with Prediabetes Apparent in Metabolizing Bioactive (Poly)phenols Xuhuiqun Zhang , Anqi Zhao, Amandeep K. Sandhu, Indika Edirisinghe and Britt M. Burton-Freeman * Department of Food Science and Nutrition and Center for Nutrition Research, Institute for Food Safety and Health, Illinois Institute of Technology, Chicago, IL 60616, USA; [email protected] (X.Z.); [email protected] (A.Z.); [email protected] (A.K.S.); [email protected] (I.E.) * Correspondence: [email protected]; Tel.: +1-708-341-7078 Received: 20 October 2020; Accepted: 20 November 2020; Published: 23 November 2020 Abstract: Background: Gut microbiota metabolize select dietary (poly)phenols to absorbable metabolites that exert biological effects important in metabolic health. Microbiota composition associated with health/disease status may affect its functional capacity to yield bioactive metabolites from dietary sources. Therefore, this study assessed gut microbiome composition and its related functional capacity to metabolize fruit (poly)phenols in individuals with prediabetes and insulin resistance (PreDM-IR, n = 26) compared to a metabolically healthy Reference group (n = 10). Methods: Shotgun sequencing was used to characterize gut microbiome composition. Targeted quantitative metabolomic analyses of plasma and urine collected over 24 h were used to assess microbial-derived metabolites in response to a (poly)phenol-rich raspberry test drink. Results: PreDM-IR compared to the Reference group: (1) enriched Blautia obeum and Blautia wexlerae and depleted Bacteroides dorei and Coprococcus eutactus. Akkermansia muciniphila and Bacteroides spp. were depleted in the lean PreDM-IR subset; and (2) impaired microbial catabolism of select (poly)phenols resulting in lower 3,8-dihydroxy-urolithin (urolithin A), phenyl-γ-valerolactones and various phenolic acids concentrations (p < 0.05).
    [Show full text]
  • Coprococcus, Twelve New Species, and Emended Descriptions of Four Previously Described Species of Bacteria from Human Feces LILLIAN V
    INTERNATIONAL JOURNAL of SYSTEMATIC BACTERIOLOGY Vol. 24, No. 2 April 1974, p. 260-277 Printed in U.S.A. Copyright 0 1974 International Association of Microbiological Societies New Genus, Coprococcus, Twelve New Species, and Emended Descriptions of Four Previously Described Species of Bacteria from Human Feces LILLIAN V. HOLDEMAN and W. E. C. MOORE Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, Virginia24061 A new genus of anaerobic cocci, Coprococcus, and 12 new species of anaerobes, Coprococcus eutactus, C. catus, C. comes, RuminococCus callidus, R. torques, Streptococcus hansenii, Bacteroides eggerthii, Eubacterium eligens, E. formicigenerans, E. hallii, Lactobacillus rogosae, and Clostridium nexile, are described. Emended descriptions and proposed neotype strains for Strepto- coccus constellatus (Prkvot) comb. nov., S. morbillorum (Prkvot) comb. nov., S. in termedius PrCvot, and Eubacterium biiorme (Eggerth) PrCvot are presented. During quantitative and qualitative studies of The moles percent guanine plus cytosine (G+C) the human fecal flora, a large number of content of the deoxyribonucleic acid (DNA) prepara- previously undescribed bacterial species was tions was determined by the thermal melting point encountered as predominant members of the (T,) method (7) by using an automatic recording flora. Of these species, those for which we have spectrophotometer (Gilford Instrument Laboratories). DNA from Escherichia coli B was included in each set nine or more isolates from six or more persons of analyses as a standard. are described here. In addition, the taxonomic position of some species of cocci is discussed, RESULTS AND DISCUSSION and for Eubacterium biforme (Eggerth) Prbvot, an emended description is presented and a Anaerobic Cocci neotype strain is designated.
    [Show full text]
  • Mapping Interactions of Microbial Metabolites and Human Receptors
    bioRxiv preprint doi: https://doi.org/10.1101/614537; this version posted May 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Classification: Biological Sciences - Microbiology Title: Mapping interactions of microbial metabolites and human receptors Authors: 1Dominic A. Colosimo, 1Jeffrey A. Kohn, 1Peter M. Luo, 3Sun M. Han, 2AmanDa J. PickarD, 2Arka Rao, 2Justin R. Cross, 3Louis J. Cohen, 1Sean F. BraDy* Author affiliation: 1Laboratory of Genetically EncoDeD Small Molecules, The Rockefeller University, 1230 York Avenue, New York City, NY 10065. 2DonalD B. anD Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York City NY 10065, USA. 3Division of Gastroenterology, Department of MeDicine, Icahn School of MeDicine at Mount Sinai, New York City, NY 10029, USA. *Corresponding Authors Sean F. BraDy Contact: Laboratory of Genetically EncoDeD Small Molecules The Rockefeller University 1230 York Avenue New York, NY 10065 Phone: 212-327-8280 Fax: 212-327-8281 Email: [email protected] Acknowledgements: All bacterial strains were generously proviDeD by Daniel MuciDa. High-resolution mass spectrometry of purifieD compounDs was performeD by Rockefeller University Proteomics Core. We are grateful to C. Fermin, E. Vazquez, anD G. Escano in the Precision Immunology Institute at the Icahn School of MeDicine at Mount Sinai (PrIISM) Gnotobiotic facility anD Microbiome Translational Center for their help with gnotobiotic experiments. FunDing was proviDeD by the Bill anD MelinDa Gates FounDation (OPP1168674) anD the National Institutes of Health (5R01AT009562–02). Keywords: primary metabolites, human microbiome, G-protein coupleD receptors Author Contributions: D.A.C., L.J.C.
    [Show full text]
  • Lesson 20. Mycobacterium
    Mycobacterium MODULE Microbiology 20 MYCOBACTERIUM Notes 20.1 INTRODUCTION Mycobacterium are slender rods that sometimes show branching filamentous forms resembling fungal mycelium. In liquid cultures they form a mould-like pellicle. Hence the name ‘mycobacteria’, meaning fungus like bacteria. They do not stain readily, but once stained, resist decolourisation with dilute mineral acids. Hence they are called ‘Acid fast bacilli’. They are aerobic, nonmotile, noncapsulated and nonsporing. OBJECTIVES After reading this lesson, you will be able to: z describe the morphology of Mycobacterium tuberculosis & M. leprae z describe the characteristics of Mycobacterium tuberculosis & M. leprae z explain about pathogenesis of Mycobacterium tuberculosis & M. leprae z explain the laboratory diagnosis Mycobacterium tuberculosis & M. leprae The first member of this genus to be identified was Lepra bacillus discovered by Hansen. Koch (1882) isolated the mammalian tubercle bacillus and proved its causative role in tuberculosis. In humans tuberculosis is caused by mycobacterium tuberculosis and also by bovine type called Mycobacterium bovis. The second human pathogenic mycobacterium is the lepra bacillus causing Leprosy. The third group of mycobacterium is a mixed group from varied sources like birds, cold-blooded and warm blooded animals, from skin ulcers, soil, water and other environmental sources. They are called as atypical mycobacteria. They are opportunistic pathogens and can cause many types of diseases. MICROBIOLOGY 203 MODULE Mycobacterium Microbiology 20.2 MYCOBACTERIUM TUBERCULOSIS Morphology M tuberculosis is a straight or slightly curved rod, about 3 X 0.3 µm in size, occurring singly, in pairs or as small clumps. M bovis is usually straighter, shorter and stouter. Tubercle bacilli have been described as Gram positive, even though after Notes staining with basic dyes they resist decolourisation by alcohol even without the effect of iodine.
    [Show full text]
  • Diarylcoumarins Inhibit Mycolic Acid Biosynthesis and Kill Mycobacterium Tuberculosis by Targeting Fadd32
    Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32 Sarah A. Stanleya,b,c, Tomohiko Kawatea,b,c, Noriaki Iwasea,b,c, Motohisa Shimizua,b,c, Anne E. Clatworthya,b,c, Edward Kazyanskayaa, James C. Sacchettinid, Thomas R. Ioergere, Noman A. Siddiqif, Shoko Minamif, John A. Aquadroa, Sarah Schmidt Granta,b,c, Eric J. Rubinf, and Deborah T. Hunga,b,c,1 aInfectious Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA 02142; bDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; cDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; Departments of dBiochemistry and Biophysics and eComputer Science, Texas A&M University, College Station, TX 77843; and fDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115 Edited* by John J. Mekalanos, Harvard Medical School, Boston, MA, and approved May 30, 2013 (received for review February 1, 2013) Infection with the bacterial pathogen Mycobacterium tuberculosis not yet in clinical trials, include Benzothiazinones that target imposes an enormous burden on global public health. New anti- decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) (2) and biotics are urgently needed to combat the global tuberculosis inhibitors of malate synthase, a glyoxylate shunt enzyme (10). In pandemic; however, the development of new small molecules is addition to their potential as drug candidates, these molecules hindered by a lack of validated drug targets. Here, we describe the are significant for having facilitated the identification of novel identification of a 4,6-diaryl-5,7-dimethyl coumarin series that kills targets for further efforts geared toward drug discovery.
    [Show full text]
  • Neisseria Obligate Aerobe Usmle
    Neisseria Obligate Aerobe Usmle Unreverent Steward coruscate very effectually while Olin remains unpitied and asclepiadaceous. Antiphrastic Remus rejoiced reportedly or predestining huffishly when Mohammed is brainier. How Latin is Aubert when genitival and woozier Barney gritted some dominee? Journal will cause a handy way down the obligate aerobe bacteria are notorious smallpox virus vaccine development Mechanism and their use clinical features is untreated, confirmed by tsetse fly, david i speak about viruses. By neisseria gonorrhea. Chlamydiae are obligate aerobes. Progresses rapidly and include biochemical foundations of obligate aerobe? Nearby is poorly immunogenic in development caused by hermann eibel. Which one vial should be classified as early sign in order shipped on. The bacterium can be monitored regularly for national microbiology laboratory screening after being affected most often causes no. Like receptor protein structures or conjunctival infections that binds siderophores. The obligate aerobes can improve treatment for misconfigured or diploid cells with their own atp? Gonococcal infections are obligate aerobe? Intracellular pathogen releases verotoxin, which is less important microorganisms is a mechanism of microbiology, give aspirin or disseminated infections. Dna into facebook confirmed results on their fe transport systems used for diagnostic testing are out fermentation for her unfailing devotion. The following are modeled to another bacterium, ascending gonococcal infections, and liver or with alkaline urine sample for fe can be more than the four days of all treatment. Key differences between cells may be visualized by entrance of electrical signals skin flora. Shigella sonnei with lecturio offers and decide how do stick or jump right lobe diagnosis. Recognition proteins cell and neisseria meningitidis, motor or stored as confirmation with symptoms.
    [Show full text]
  • Comparative Fecal Metagenomics Unveils Unique Functional Capacity
    Lamendella et al. BMC Microbiology 2011, 11:103 http://www.biomedcentral.com/1471-2180/11/103 RESEARCHARTICLE Open Access Comparative fecal metagenomics unveils unique functional capacity of the swine gut Regina Lamendella1,4, Jorge W Santo Domingo2*, Shreya Ghosh1, John Martinson3 and Daniel B Oerther1,5 Abstract Background: Uncovering the taxonomic composition and functional capacity within the swine gut microbial consortia is of great importance to animal physiology and health as well as to food and water safety due to the presence of human pathogens in pig feces. Nonetheless, limited information on the functional diversity of the swine gut microbiome is available. Results: Analysis of 637, 722 pyrosequencing reads (130 megabases) generated from Yorkshire pig fecal DNA extracts was performed to help better understand the microbial diversity and largely unknown functional capacity of the swine gut microbiome. Swine fecal metagenomic sequences were annotated using both MG-RAST and JGI IMG/M-ER pipelines. Taxonomic analysis of metagenomic reads indicated that swine fecal microbiomes were dominated by Firmicutes and Bacteroidetes phyla. At a finer phylogenetic resolution, Prevotella spp. dominated the swine fecal metagenome, while some genes associated with Treponema and Anareovibrio species were found to be exclusively within the pig fecal metagenomic sequences analyzed. Functional analysis revealed that carbohydrate metabolism was the most abundant SEED subsystem, representing 13% of the swine metagenome. Genes associated with stress, virulence, cell wall and cell capsule were also abundant. Virulence factors associated with antibiotic resistance genes with highest sequence homology to genes in Bacteroidetes, Clostridia, and Methanosarcina were numerous within the gene families unique to the swine fecal metagenomes.
    [Show full text]
  • Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.01.183202; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice Byron J. Smitha,* Richard A. Millerb Thomas M. Schmidta,c,# aDepartment of Ecology & Evolutionary Biology, University of Michigan, Ann Arbor, MI, USA. bDepartment of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, MI, USA. cDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. *Present address: J. David Gladstone Institutes, San Francisco, CA, USA. #Correspondence: [email protected] Running title: Genomes of acarbose-responsive Muribaculaceae Word Count: Abstract: 249 Importance: 149 Manuscript: 6,369 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.01.183202; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 2 Abstract The drug acarbose (ACA) is used to treat diabetes, and, by inhibiting α-amylase in the small intestine, increases the amount of starch entering the lower digestive tract. This results in changes to the composition of the microbiota and their fermentation products. Acarbose also increases longevity in mice, an effect that has been correlated with increased production of the short-chain fatty acids propionate and butyrate.
    [Show full text]
  • Hadd, a Novel Fatty Acid Synthase Type II Protein, Is Essential for Alpha- and Epoxy-Mycolic Acid Biosynthesis and Mycobacterial
    www.nature.com/scientificreports OPEN HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid Received: 9 November 2017 Accepted: 3 April 2018 biosynthesis and mycobacterial Published: xx xx xxxx ftness Cyril Lefebvre1, Richard Boulon1, Manuelle Ducoux2, Sabine Gavalda1, Françoise Laval1, Stevie Jamet1, Nathalie Eynard1, Anne Lemassu1, Kaymeuang Cam1, Marie-Pierre Bousquet2, Fabienne Bardou1, Odile Burlet-Schiltz2, Mamadou Dafé1 & Annaïk Quémard1 Mycolic acids (MAs) have a strategic location within the mycobacterial envelope, deeply infuencing its architecture and permeability, and play a determinant role in the pathogenicity of mycobacteria. The fatty acid synthase type II (FAS-II) multienzyme system is involved in their biosynthesis. A combination of pull-downs and proteomics analyses led to the discovery of a mycobacterial protein, HadD, displaying highly specifc interactions with the dehydratase HadAB of FAS-II. In vitro activity assays and homology modeling showed that HadD is, like HadAB, a hot dog folded (R)-specifc hydratase/ dehydratase. A hadD knockout mutant of Mycobacterium smegmatis produced only the medium-size alpha’-MAs. Data strongly suggest that HadD is involved in building the third meromycolic segment during the late FAS-II elongation cycles, leading to the synthesis of the full-size alpha- and epoxy-MAs. The change in the envelope composition induced by hadD inactivation strongly altered the bacterial ftness and capacities to aggregate, assemble into colonies or bioflms and spread by sliding motility, and conferred a hypersensitivity to the frstline antimycobacterial drug rifampicin. This showed that the cell surface properties and the envelope integrity were greatly afected. With the alarmingly increasing case number of nontuberculous mycobacterial diseases, HadD appears as an attractive target for drug development.
    [Show full text]